Diabetes Care Devices | Medtech 360 | Market Insights | United States

Publish date: September 2017

Login to access report

Strong growth in the US diabetes care device market over the forecast period will be fueled by a rapidly growing diabetes patient population in the country, and by a number of new product launches that will generate significant market revenues. The opportunities presented in the diabetes care device market will entice companies to invest in R&D and to partner with digital technology companies to develop patient-centric products.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for diabetes care devices in the US across a 10-year period.


There is a great deal of innovation in the US diabetes care market, including the launch of the first hybrid closed-loop "artificial pancreas."

Which markets will be the most impacted by new technology, and how will these innovations affect these markets?

What strategies are competitors using to increase their presence in this dynamic market?

The insulin delivery device market is very large and will continue to expand rapidly through 2026.

What factors are driving this rapid increase in the market?

Which devices will help drive the most growth in the insulin delivery device space?

Medicare reimbursement has changed for both type 1 and type 2 diabetes patients.

Which markets are affected by changes in reimbursement?

How does reimbursement differ for different diabetes patients?

Table of contents

  • United States
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Products Covered
    • Version History
    • Diabetes Care Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Emerging Technologies
        • Product Improvements and Innovations
        • Reimbursement
        • Mergers, Acquisitions, and Partnerships
        • Pricing Strategies
        • Product Portfolio Management
      • Market Developments
    • Glucose Monitoring Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Self-Monitoring Blood Glucose Devices
        • Continuous Glucose Monitoring Devices
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
    • Insulin Delivery Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Multiple Daily Injection Devices
        • Insulin Pumps
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Emerging Technologies
        • Product Improvements and Innovations
        • Pricing Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Paul Desormeaux, MSc

Paul Desormeaux is a senior analyst within the Endoscopy and Aesthetics Medtech Insights team at Decision Resources Group, specializing in the fields of neurosurgery, neurostimulation, gastroenterology, obesity, diabetes, and regenerative medicine. He has authored and presented a number of thought leadership pieces on the opioid crisis, the growing diabetes epidemic, and the current state of health care in the US. Paul holds a Bachelor's degree from Queen’s University and a Master's degree in Biochemistry from the University of Western Ontario.